Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Feb 21, 2022

BEN GUERIR, Morocco and SCOTTSDALE, Ariz., Feb. 21, 2022(GLOBE NEWSWIRE) -- Mohammed VI Polytechnic University (French: Université Mohammed VI Polytechnique, commonly abbreviated as UM6P), a leading Moroccan research university, today announced a comprehensive artificial intelligence R&D partnership with ALPHA10X, an award-winning AI startup concentrated on life sciences innovation and investment.

The partnership, to be based on the main UM6P campus in the historic city of Ben Guerir, near Marrakech, is dedicated to building Africa’s leading AI center concentrated on shaping the future of life sciences innovation and investment. Operating as a bridge between France, Morocco, and Silicon Valley, the goal is to recruit, and develop UM6P’s brightest AI graduates, in a cutting-edge, intellectually challenging startup environment, in Morocco. The venture, which comprises a UM6P investment preference, will include joint-development and technology transfer projects.

UM6P is an applied research and innovation institution, concentrated on economic and human development, with a focus on Africa. UM6P has international partnerships with leading universities around the globe, including the Massachusetts Institute ofTechnology, Columbia Business School, Max Planck Society, HEC Paris, Mines Paris Tech, the École Polytechnique Fédérale de Lausanne, McGill University, and Sciences Po. The university emerged as part of the "Green City"project, a sustainable city development project located outside of Ben Guerir, with a special interest in promoting research, education, and development in Africa.

ALPHA10X is an AI startup with offices in the U.S., France, Luxembourg, and Morocco. Premised on the idea that AI will make the source code of life – the algorithmic processes, machines, and computation in nature itself – available to innovation, ALPHA10X is an impact investment platform that shapes billions of data points into the actionable knowledge and predictions that investors need to understand and value their life science ventures. The team includes prominent AI scholars and scientists with PhDs and advanced degrees from elite schools in eighteen countries. The company has been recognized by Microsoft, in partnership with INRIA, France’s National Institute for Research in Digital Science and Technology, as one of the leading AI startups in Europe, and by the European Union for market-creating innovations that shape the future.

“We’re thrilled to partner with ALPHA10X on a range of R&D ventures well aligned to our mission,” said Hicham El Habti, the president of UM6P. “The university is a platform for experimentation, which our students refer to as a ‘School of Life’. We must develop and retain Africa’s top talent in Africa, and we need business partners innovating at the edge of science to realize this dream.”

“If Morocco is to become a “Startup Nation” we must cultivate an ecosystem of innovation in the country,” said Professor Amal El Fallah Segrouchni, Head of Ai Movement - International Artificial Intelligence Center of Morocco, that aims to foster the emergence of Moroccan expertise in AI. “We need Silicon Valley know-how, challenging AI projects, and investment, to develop Morocco’s potential as a leading AI hub.The ALPHA10X partnership brings all this and more.”

“Silicon Valley is no longer a region. It is a platform, and a state of mind,” said Robert Marcus, ALPHA10X CEO and a former Silicon Valley venture capitalist. “We’re excited to invest in Africa, and to partner with UM6P. Highly-educated, determined risk-takers around the world, including Morocco, are proving that they can innovate as aggressively, create as ingeniously, and work as hard as their contemporaries in more mature innovation hubs.”  

For fifty years, the global heart of tech innovation has been Silicon Valley, where entrepreneurs congregated from around the world to drive cycle after cycle of rapid advances in computing. The Valley will remain a primary source of the exponential technologies needed to build a better world. However, the Bay Area by itself cannot produce all the exponential solutions needed — solutions that can create immediate, substantial improvements in life on earth.

The globalization of R&D and innovation has devolved power away from large organizations and closed systems, including Silicon Valley itself, moving it to highly agile startups in technology hubs around the world. Emerging hubs, like Morocco, combine the same key features as the original: great universities, talent, enthusiasm, infrastructure, state and local government support, and the ability to attract private capital. The partnership is a robust proof point of that innovation potential, in Morocco. The ambition of the venture is to impact and positively improve the lives of one billion people or more, with an emphasis on Africa.

Contact:
Aurélie (Lily) Lecomte

ALPHA10X lily@alpha10x.com
+33 6 95 96 49 34

About UM6P

Mohammed VI Polytechnic University is an institution oriented towards applied research and innovation.The University is engaged in economic and human development and puts research and innovation as a top priority, which enables it to consolidate Morocco’s frontline position in these fields, in a unique partnership-based approach and boosting skills training relevant for the future of Africa. At the international level, the University has woven partnerships with world renowned institutions, which has led to outstanding collaborations for research and innovation. Its culturally diverse campus is designed to foster scientific, cultural, sporting and artistic emulation.

About ALPHA10X

Founded in 2018, with business headquarters in the USA, and R&D in France and Morocco, ALPHA10Xis an award-winning AI-powered life sciences investment platform. The team includes prominent AI scholars and scientists with PhDs and advanced degrees from elite schools in eighteen countries. The company has been recognized by Microsoft, in partnership with INRIA, France’s National Institute for Research in Digital Science and Technology, as one of the leading AI startups in Europe, and by the European Union for market-creating innovations that shape the future. Purposed for the emerging class of ‘impact unicorns’, startups that a revalued at one billion dollars or more and improve the lives of one billion people or more, we connect the people, capital, and ideas that promise to solve the world’s greatest challenges.

Related news

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

Nov 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Industry analyst discusses biotech firm lifecycle

Apr 6
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

How Artificial Intelligence is Transforming the Healthcare Industry

Oct 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Global data and analysis on dealmaking, funding, and exits in private-market companies

Sep 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report

Dec 10
,
2020
AI
Cleantech
Healthcare
Investment
Life Science
Press

Venture Investors Turn To AI To Find Deal

Sep 27
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Platform that Offers AI Investment Advice MDOTM Raises €6.2 million Series B, Currently holds € 750 million AUA

Dec 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

390 Startup Failure Post-Mortems

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Bridging the ESG Valley of Death

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie